Pregnancy: Category C.
Topiramate should be used during pregnancy only if the potential benefit outweighs the potential risk to the fetus. There is an increased risk for the development of cleft lip and/or cleft palate (oral clefts) in infants born to women treated with topiramate during pregnancy. Topiramate may cause serious adverse fetal effects.
Lactation: Topiramate is excreted in the breast milk. Use of topiramate while breastfeeding is not recommended.
Other Services
Country
Account